Healius Overview

  • Year Founded
  • 1985

Year Founded

  • Status
  • Public

  • Employees
  • 11,000

Employees

  • Stock Symbol
  • HLS

Stock Symbol

  • Investments
  • 9

  • Share Price
  • $0.41
  • (As of Thursday Closing)

Healius General Information

Description

Healius is one of Australia's pathology providers, operating a national network of laboratories and collection centres. Pathology generates nearly all group revenue, the majority of which comes from bulk-billed tests funded through the government's Medicare Benefits Schedule, with the remainder from public hospital contracts, private health funds, and specialty services, including genomics and veterinary pathology.

Contact Information

Formerly Known As
Primary Health Care
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Level 22
  • 161 Castlereagh Street
  • Sydney, New South Wales 2000
  • Australia
+61 (02)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Hospitals/Inpatient Services
Clinics/Outpatient Services
Stock Exchange
ASX
Vertical(s)
Corporate Office
  • Level 22
  • 161 Castlereagh Street
  • Sydney, New South Wales 2000
  • Australia
+61 (02)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Healius Stock Performance

As of 19-Nov-2026, Healius’s stock price is $0.41. Its current market cap is $296M with 726M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.41 $0.39 $0.21 - $0.70 $296M 726M 5.1M -$0.39

Healius Financials Summary

As of 30-Jun-2026, Healius has a trailing 12-month revenue of $930M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 806,351 806,351 1,210,630 1,741,616
Revenue 930,245 930,245 869,723 1,144,351
EBITDA (68,082) (68,082) (195,853) (195,356)
Net Income (281,539) (281,539) (97,829) (423,217)
Total Assets 975,576 975,576 1,160,717 1,993,704
Total Debt 685,711 685,711 595,578 1,068,036
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Healius Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Healius‘s full profile, request access.

Request a free trial

Healius Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Healius is one of Australia's pathology providers, operating a national network of laboratories and collection centres.
Laboratory Services (Healthcare)
Sydney, Australia
11,000 As of 2022

Elmwood Park, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Healius Competitors (1)

One of Healius’s competitors is BioReference Health, a Corporate Backed or Acquired company based in Elmwood Park, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioReference Health Corporate Backed or Acquired Elmwood Park, NJ
You’re viewing 1 of 1 competitors. Get the full list »

Healius Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Healius Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Healius‘s full profile, request access.

Request a free trial

Healius Investments & Acquisitions (9)

Healius’s most recent deal was a Merger/Acquisition with Agilex Biolabs for . The deal was made on 31-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Agilex Biolabs 31-Jan-2022 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Axis Diagnostic Holdings 01-Jul-2021 Merger/Acquisition Laboratory Services (Healthcare)
Montserrat Day Hospitals 21-Sep-2018 Merger/Acquisition Hospitals/Inpatient Services
Brisbane Private Imaging 01-Jan-2018 Merger/Acquisition Clinics/Outpatient Services
Healthscope (Queensland Operations) 16-Jun-2016 Merger/Acquisition Clinics/Outpatient Services
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Healius ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

19.09 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Services

Subindustry

of 97

Rank

Percentile

To view Healius’s complete esg history, request access »

Healius Exits (4)

Healius’s most recent exit was on 21-Sep-2018 from Montserrat Day Hospitals. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Montserrat Day Hospitals 21-Sep-2018 Completed
Transport Health 01-Nov-2014 Completed
Faulding 08-Nov-2007 Completed
Faulding PIPE Completed
To view Healius’s complete exits history, request access »

Healius Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Agilex Biolabs Thebarton, Australia 1996

Healius FAQs

  • When was Healius founded?

    Healius was founded in 1985.

  • Where is Healius headquartered?

    Healius is headquartered in Sydney, Australia.

  • What is the size of Healius?

    Healius has 11,000 total employees.

  • What industry is Healius in?

    Healius’s primary industry is Laboratory Services (Healthcare).

  • Is Healius a private or public company?

    Healius is a Public company.

  • What is Healius’s stock symbol?

    The ticker symbol for Healius is HLS.

  • What is the current stock price of Healius?

    As of 19-Nov-2026 the stock price of Healius is $0.41.

  • What is the current market cap of Healius?

    The current market capitalization of Healius is $296M.

  • What is Healius’s current revenue?

    The trailing twelve month revenue for Healius is $930M.

  • Who are Healius’s competitors?

    BioReference Health is a competitor of Healius.

  • What is Healius’s annual earnings per share (EPS)?

    Healius’s EPS for 12 months was -$0.39.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process